CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
-2.75%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.1B
AUM Growth
+$273M
(+2%)
Cap. Flow
-$498M
Cap. Flow
% of AUM
-3.53%
Top 10 Holdings %
Top 10 Hldgs %
32.88%
Holding
711
New
–
Increased
221
Reduced
319
Closed
43
Top Buys
| 1 |
XP
XP
|
$630M |
| 2 |
Amgen
AMGN
|
$44.8M |
| 3 |
NVIDIA
NVDA
|
$34.9M |
| 4 |
MINISO
MNSO
|
$32M |
| 5 |
Intuitive Surgical
ISRG
|
$31.7M |
Top Sells
| 1 |
Teck Resources
TECK
|
$474M |
| 2 |
Visa
V
|
$55.3M |
| 3 |
Johnson & Johnson
JNJ
|
$51.8M |
| 4 |
Microsoft
MSFT
|
$38.9M |
| 5 |
Danaher
DHR
|
$36.7M |
Sector Composition
| 1 | Healthcare | 26.08% |
| 2 | Technology | 25.64% |
| 3 | Financials | 11.81% |
| 4 | Industrials | 7.9% |
| 5 | Materials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Blackrock
BLK
$170B
| $6.57M | 0.05% |
10,158
-186
| -2% | -$120K |
|
277
RenaissanceRe
RNR
$11.3B
| $6.55M | 0.05% |
33,105
-2,817
| -8% | -$558K |
|
278
BioNTech
BNTX
$27B
| $6.55M | 0.05% |
60,303
-82,000
| -58% | -$8.91M |
|
279
PTC Therapeutics
PTCT
$4.55B
| $6.54M | 0.05% |
291,652
| – | – |
|
280
Dyne Therapeutics
DYN
$2.02B
| $6.48M | 0.05% |
723,624
| – | – |
|
281
BridgeBio Pharma
BBIO
$10.2B
| $6.46M | 0.05% |
245,000
-40,000
| -14% | -$1.05M |
|
282
Phreesia
PHR
$1.67B
| $6.43M | 0.05% |
344,168
+274,168
| +392% | +$5.12M |
|
283
Cigna
CI
$81.5B
| $6.42M | 0.05% |
22,450
-728
| -3% | -$208K |
|
284
BILL Holdings
BILL
$5.24B
| $6.36M | 0.05% |
58,549
+3,976
| +7% | +$432K |
|
285
Chart Industries
GTLS
$8.96B
| $6.35M | 0.05% |
37,537
| – | – |
|
286
Kura Oncology
KURA
$713M
| $6.31M | 0.04% |
691,422
| – | – |
|
287
Moody's
MCO
$89.5B
| $6.13M | 0.04% |
19,393
+3,843
| +25% | +$1.22M |
|
288
Badger Meter
BMI
$5.39B
| $5.94M | 0.04% |
41,254
+32,737
| +384% | +$4.71M |
|
289
Arrowhead Research
ARWR
$4.02B
| $5.91M | 0.04% |
220,054
| – | – |
|
290
Eversource Energy
ES
$23.6B
| $5.79M | 0.04% |
99,591
-61,035
| -38% | -$3.55M |
|
291
Zimmer Biomet
ZBH
$20.9B
| $5.74M | 0.04% |
51,165
+8,534
| +20% | +$958K |
|
|
MORF
292
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $5.73M | 0.04% |
249,933
| – | – |
|
293
Clorox
CLX
$15.5B
| $5.62M | 0.04% |
42,866
+29,530
| +221% | +$3.87M |
|
294
Treace Medical Concepts
TMCI
$453M
| $5.61M | 0.04% |
427,972
+357,972
| +511% | +$4.69M |
|
|
ITOS
295
DELISTED
iTeos Therapeutics
ITOS
| $5.6M | 0.04% |
511,537
-100,010
| -16% | -$1.1M |
|
296
Pliant Therapeutics
PLRX
$114M
| $5.46M | 0.04% |
315,000
+50,000
| +19% | +$867K |
|
297
Sutro Biopharma
STRO
$89.9M
| $5.34M | 0.04% |
1,538,234
-90,000
| -6% | -$312K |
|
298
Okta
OKTA
$16.1B
| $5.32M | 0.04% |
65,282
-4,483
| -6% | -$365K |
|
299
Burlington
BURL
$18.4B
| $5.31M | 0.04% |
39,239
+35,829
| +1,051% | +$4.85M |
|
300
Akamai
AKAM
$11.3B
| $5.26M | 0.04% |
49,404
+2,126
| +4% | +$227K |
|